We are pleased to announce the addition of Jill Burdette to the SalivIQ board of advisors! Jill brings 30 years of business development and technology sales experience to this role, and she has
Last month Founder & CEO of SalivIQ, Julia Halterman, spoke about the incredible potential of using saliva to diagnose strep throat at the SalivaDirect Conference in Washington D.C. She was accompanied by an
We are pleased to announce that SalivIQ has been accepted to participate in NSF's I-Corps Regional Cohort this July! This accelerator program through GMU is focused on reimagining the innovation process from conception
Join us in Washington, DC from June 5-7, 2024 at the Third Annual SalivaDirect Conference to network with diagnostic developers, laboratories, academicians, and public health practitioners. Julia Halterman, PhD, Founder and CEO of
